nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—Disease progression—Telbivudine—hepatitis B	0.0318	0.0641	CcSEcCtD
Trametinib—Abdominal pain lower—Telbivudine—hepatitis B	0.0218	0.044	CcSEcCtD
Trametinib—MAP2K2—blood plasma—hepatitis B	0.0177	0.298	CbGeAlD
Trametinib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.0142	0.0286	CcSEcCtD
Trametinib—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00866	0.0175	CcSEcCtD
Trametinib—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0081	0.0163	CcSEcCtD
Trametinib—Rhabdomyolysis—Telbivudine—hepatitis B	0.00785	0.0158	CcSEcCtD
Trametinib—Cardiomyopathy—Lamivudine—hepatitis B	0.00765	0.0154	CcSEcCtD
Trametinib—MAP2K1—blood—hepatitis B	0.00736	0.124	CbGeAlD
Trametinib—Gingival bleeding—Lamivudine—hepatitis B	0.0069	0.0139	CcSEcCtD
Trametinib—MAP2K2—blood—hepatitis B	0.00648	0.109	CbGeAlD
Trametinib—Folliculitis—Lamivudine—hepatitis B	0.00623	0.0125	CcSEcCtD
Trametinib—CYP2C8—blood plasma—hepatitis B	0.00613	0.103	CbGeAlD
Trametinib—MAP2K1—liver—hepatitis B	0.00576	0.097	CbGeAlD
Trametinib—Blood creatinine increased—Entecavir—hepatitis B	0.00575	0.0116	CcSEcCtD
Trametinib—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00561	0.0113	CcSEcCtD
Trametinib—Abdominal pain upper—Entecavir—hepatitis B	0.0056	0.0113	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00528	0.0106	CcSEcCtD
Trametinib—Pancreatitis—Entecavir—hepatitis B	0.0052	0.0105	CcSEcCtD
Trametinib—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00507	0.0102	CcSEcCtD
Trametinib—MAP2K2—liver—hepatitis B	0.00507	0.0854	CbGeAlD
Trametinib—Pain in extremity—Telbivudine—hepatitis B	0.00504	0.0102	CcSEcCtD
Trametinib—Neutropenia—Entecavir—hepatitis B	0.00496	0.00999	CcSEcCtD
Trametinib—Hyperglycaemia—Entecavir—hepatitis B	0.00478	0.00964	CcSEcCtD
Trametinib—Renal failure—Entecavir—hepatitis B	0.00465	0.00937	CcSEcCtD
Trametinib—Abdominal pain upper—Telbivudine—hepatitis B	0.0046	0.00928	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00454	0.00915	CcSEcCtD
Trametinib—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00453	0.00914	CcSEcCtD
Trametinib—Haematuria—Entecavir—hepatitis B	0.00451	0.00909	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00445	0.00896	CcSEcCtD
Trametinib—Rhabdomyolysis—Lamivudine—hepatitis B	0.00442	0.00891	CcSEcCtD
Trametinib—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0044	0.00886	CcSEcCtD
Trametinib—Bone disorder—Lamivudine—hepatitis B	0.00433	0.00873	CcSEcCtD
Trametinib—Rectal haemorrhage—Lamivudine—hepatitis B	0.00433	0.00873	CcSEcCtD
Trametinib—Oropharyngeal pain—Lamivudine—hepatitis B	0.0043	0.00867	CcSEcCtD
Trametinib—Oedema peripheral—Entecavir—hepatitis B	0.00418	0.00843	CcSEcCtD
Trametinib—Abdominal discomfort—Telbivudine—hepatitis B	0.00418	0.00842	CcSEcCtD
Trametinib—CYP3A4—blood plasma—hepatitis B	0.00415	0.0699	CbGeAlD
Trametinib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00409	0.00824	CcSEcCtD
Trametinib—Neutropenia—Telbivudine—hepatitis B	0.00407	0.00821	CcSEcCtD
Trametinib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00407	0.0082	CcSEcCtD
Trametinib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00406	0.00818	CcSEcCtD
Trametinib—Renal failure—Telbivudine—hepatitis B	0.00382	0.00769	CcSEcCtD
Trametinib—Mental disorder—Entecavir—hepatitis B	0.00372	0.00749	CcSEcCtD
Trametinib—Malnutrition—Entecavir—hepatitis B	0.0037	0.00745	CcSEcCtD
Trametinib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00361	0.00727	CcSEcCtD
Trametinib—Mouth ulceration—Lamivudine—hepatitis B	0.00354	0.00713	CcSEcCtD
Trametinib—Back pain—Adefovir Dipivoxil—hepatitis B	0.00349	0.00703	CcSEcCtD
Trametinib—Connective tissue disorder—Telbivudine—hepatitis B	0.00343	0.00691	CcSEcCtD
Trametinib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00333	0.00671	CcSEcCtD
Trametinib—Leukopenia—Entecavir—hepatitis B	0.00331	0.00667	CcSEcCtD
Trametinib—Cough—Adefovir Dipivoxil—hepatitis B	0.00315	0.00634	CcSEcCtD
Trametinib—Mediastinal disorder—Telbivudine—hepatitis B	0.00314	0.00633	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00312	0.0063	CcSEcCtD
Trametinib—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00307	0.00619	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00305	0.00614	CcSEcCtD
Trametinib—Malnutrition—Telbivudine—hepatitis B	0.00304	0.00612	CcSEcCtD
Trametinib—Infection—Entecavir—hepatitis B	0.003	0.00604	CcSEcCtD
Trametinib—Dysgeusia—Telbivudine—hepatitis B	0.00297	0.00599	CcSEcCtD
Trametinib—Nervous system disorder—Entecavir—hepatitis B	0.00296	0.00596	CcSEcCtD
Trametinib—Back pain—Telbivudine—hepatitis B	0.00294	0.00592	CcSEcCtD
Trametinib—Skin disorder—Entecavir—hepatitis B	0.00293	0.0059	CcSEcCtD
Trametinib—Muscle spasms—Telbivudine—hepatitis B	0.00292	0.00588	CcSEcCtD
Trametinib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00289	0.00581	CcSEcCtD
Trametinib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00288	0.00581	CcSEcCtD
Trametinib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00286	0.00576	CcSEcCtD
Trametinib—Insomnia—Entecavir—hepatitis B	0.00273	0.0055	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00268	0.0054	CcSEcCtD
Trametinib—Cough—Telbivudine—hepatitis B	0.00265	0.00534	CcSEcCtD
Trametinib—Dehydration—Lamivudine—hepatitis B	0.00264	0.00532	CcSEcCtD
Trametinib—Gastrointestinal disorder—Entecavir—hepatitis B	0.0026	0.00525	CcSEcCtD
Trametinib—Fatigue—Entecavir—hepatitis B	0.0026	0.00524	CcSEcCtD
Trametinib—Abdominal pain upper—Lamivudine—hepatitis B	0.00259	0.00523	CcSEcCtD
Trametinib—Arthralgia—Telbivudine—hepatitis B	0.00258	0.00521	CcSEcCtD
Trametinib—Myalgia—Telbivudine—hepatitis B	0.00258	0.00521	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00257	0.00517	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00256	0.00515	CcSEcCtD
Trametinib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00256	0.00515	CcSEcCtD
Trametinib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00254	0.00512	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00251	0.00505	CcSEcCtD
Trametinib—Gastrointestinal pain—Entecavir—hepatitis B	0.00247	0.00497	CcSEcCtD
Trametinib—Nervous system disorder—Telbivudine—hepatitis B	0.00243	0.0049	CcSEcCtD
Trametinib—Thrombocytopenia—Telbivudine—hepatitis B	0.00243	0.00489	CcSEcCtD
Trametinib—Pancreatitis—Lamivudine—hepatitis B	0.00241	0.00485	CcSEcCtD
Trametinib—Skin disorder—Telbivudine—hepatitis B	0.00241	0.00485	CcSEcCtD
Trametinib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00241	0.00485	CcSEcCtD
Trametinib—Body temperature increased—Entecavir—hepatitis B	0.00238	0.0048	CcSEcCtD
Trametinib—Abdominal pain—Entecavir—hepatitis B	0.00238	0.0048	CcSEcCtD
Trametinib—Abdominal discomfort—Lamivudine—hepatitis B	0.00235	0.00474	CcSEcCtD
Trametinib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00233	0.00469	CcSEcCtD
Trametinib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00233	0.00469	CcSEcCtD
Trametinib—Neutropenia—Lamivudine—hepatitis B	0.0023	0.00463	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00226	0.00455	CcSEcCtD
Trametinib—CYP2C8—blood—hepatitis B	0.00224	0.0378	CbGeAlD
Trametinib—Insomnia—Telbivudine—hepatitis B	0.00224	0.00452	CcSEcCtD
Trametinib—Hyperglycaemia—Lamivudine—hepatitis B	0.00221	0.00446	CcSEcCtD
Trametinib—Asthenia—Entecavir—hepatitis B	0.00216	0.00436	CcSEcCtD
Trametinib—Renal failure—Lamivudine—hepatitis B	0.00215	0.00434	CcSEcCtD
Trametinib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00214	0.00431	CcSEcCtD
Trametinib—Fatigue—Telbivudine—hepatitis B	0.00214	0.0043	CcSEcCtD
Trametinib—Stomatitis—Lamivudine—hepatitis B	0.00213	0.0043	CcSEcCtD
Trametinib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00211	0.00425	CcSEcCtD
Trametinib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00208	0.0042	CcSEcCtD
Trametinib—Epistaxis—Lamivudine—hepatitis B	0.00206	0.00416	CcSEcCtD
Trametinib—Diarrhoea—Entecavir—hepatitis B	0.00206	0.00416	CcSEcCtD
Trametinib—Gastrointestinal pain—Telbivudine—hepatitis B	0.00203	0.00408	CcSEcCtD
Trametinib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00201	0.00406	CcSEcCtD
Trametinib—Dizziness—Entecavir—hepatitis B	0.00199	0.00402	CcSEcCtD
Trametinib—Abdominal pain—Telbivudine—hepatitis B	0.00196	0.00395	CcSEcCtD
Trametinib—Body temperature increased—Telbivudine—hepatitis B	0.00196	0.00395	CcSEcCtD
Trametinib—Connective tissue disorder—Lamivudine—hepatitis B	0.00193	0.00389	CcSEcCtD
Trametinib—Vomiting—Entecavir—hepatitis B	0.00192	0.00386	CcSEcCtD
Trametinib—Rash—Entecavir—hepatitis B	0.0019	0.00383	CcSEcCtD
Trametinib—Dermatitis—Entecavir—hepatitis B	0.0019	0.00383	CcSEcCtD
Trametinib—Headache—Entecavir—hepatitis B	0.00189	0.00381	CcSEcCtD
Trametinib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00187	0.00377	CcSEcCtD
Trametinib—Rash—Adefovir Dipivoxil—hepatitis B	0.00186	0.00374	CcSEcCtD
Trametinib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00185	0.00374	CcSEcCtD
Trametinib—Headache—Adefovir Dipivoxil—hepatitis B	0.00184	0.00371	CcSEcCtD
Trametinib—Nausea—Entecavir—hepatitis B	0.00179	0.00361	CcSEcCtD
Trametinib—Asthenia—Telbivudine—hepatitis B	0.00178	0.00358	CcSEcCtD
Trametinib—Mediastinal disorder—Lamivudine—hepatitis B	0.00177	0.00357	CcSEcCtD
Trametinib—Chills—Lamivudine—hepatitis B	0.00176	0.00355	CcSEcCtD
Trametinib—CYP2C8—liver—hepatitis B	0.00176	0.0296	CbGeAlD
Trametinib—Pruritus—Telbivudine—hepatitis B	0.00175	0.00353	CcSEcCtD
Trametinib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00175	0.00352	CcSEcCtD
Trametinib—Malnutrition—Lamivudine—hepatitis B	0.00171	0.00345	CcSEcCtD
Trametinib—Erythema—Lamivudine—hepatitis B	0.00171	0.00345	CcSEcCtD
Trametinib—Diarrhoea—Telbivudine—hepatitis B	0.0017	0.00342	CcSEcCtD
Trametinib—Dysgeusia—Lamivudine—hepatitis B	0.00168	0.00338	CcSEcCtD
Trametinib—Back pain—Lamivudine—hepatitis B	0.00165	0.00333	CcSEcCtD
Trametinib—Muscle spasms—Lamivudine—hepatitis B	0.00164	0.00331	CcSEcCtD
Trametinib—Dizziness—Telbivudine—hepatitis B	0.00164	0.0033	CcSEcCtD
Trametinib—Anaemia—Lamivudine—hepatitis B	0.00158	0.00319	CcSEcCtD
Trametinib—Vomiting—Telbivudine—hepatitis B	0.00158	0.00317	CcSEcCtD
Trametinib—Rash—Telbivudine—hepatitis B	0.00156	0.00315	CcSEcCtD
Trametinib—Dermatitis—Telbivudine—hepatitis B	0.00156	0.00314	CcSEcCtD
Trametinib—Headache—Telbivudine—hepatitis B	0.00155	0.00313	CcSEcCtD
Trametinib—Leukopenia—Lamivudine—hepatitis B	0.00153	0.00309	CcSEcCtD
Trametinib—CYP3A4—blood—hepatitis B	0.00152	0.0256	CbGeAlD
Trametinib—Cough—Lamivudine—hepatitis B	0.00149	0.00301	CcSEcCtD
Trametinib—Nausea—Telbivudine—hepatitis B	0.00147	0.00297	CcSEcCtD
Trametinib—Myalgia—Lamivudine—hepatitis B	0.00146	0.00293	CcSEcCtD
Trametinib—Arthralgia—Lamivudine—hepatitis B	0.00146	0.00293	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00145	0.00291	CcSEcCtD
Trametinib—Dry mouth—Lamivudine—hepatitis B	0.00142	0.00287	CcSEcCtD
Trametinib—Oedema—Lamivudine—hepatitis B	0.0014	0.00281	CcSEcCtD
Trametinib—Infection—Lamivudine—hepatitis B	0.00139	0.0028	CcSEcCtD
Trametinib—Nervous system disorder—Lamivudine—hepatitis B	0.00137	0.00276	CcSEcCtD
Trametinib—Thrombocytopenia—Lamivudine—hepatitis B	0.00137	0.00275	CcSEcCtD
Trametinib—Skin disorder—Lamivudine—hepatitis B	0.00136	0.00273	CcSEcCtD
Trametinib—Hyperhidrosis—Lamivudine—hepatitis B	0.00135	0.00272	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00127	0.00256	CcSEcCtD
Trametinib—Insomnia—Lamivudine—hepatitis B	0.00126	0.00254	CcSEcCtD
Trametinib—Decreased appetite—Lamivudine—hepatitis B	0.00121	0.00245	CcSEcCtD
Trametinib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00121	0.00243	CcSEcCtD
Trametinib—Fatigue—Lamivudine—hepatitis B	0.0012	0.00243	CcSEcCtD
Trametinib—Constipation—Lamivudine—hepatitis B	0.00119	0.00241	CcSEcCtD
Trametinib—CYP3A4—liver—hepatitis B	0.00119	0.02	CbGeAlD
Trametinib—Gastrointestinal pain—Lamivudine—hepatitis B	0.00114	0.0023	CcSEcCtD
Trametinib—Body temperature increased—Lamivudine—hepatitis B	0.0011	0.00222	CcSEcCtD
Trametinib—Abdominal pain—Lamivudine—hepatitis B	0.0011	0.00222	CcSEcCtD
Trametinib—Asthenia—Lamivudine—hepatitis B	0.001	0.00202	CcSEcCtD
Trametinib—Pruritus—Lamivudine—hepatitis B	0.000988	0.00199	CcSEcCtD
Trametinib—Diarrhoea—Lamivudine—hepatitis B	0.000955	0.00193	CcSEcCtD
Trametinib—Dizziness—Lamivudine—hepatitis B	0.000923	0.00186	CcSEcCtD
Trametinib—Vomiting—Lamivudine—hepatitis B	0.000888	0.00179	CcSEcCtD
Trametinib—Rash—Lamivudine—hepatitis B	0.00088	0.00177	CcSEcCtD
Trametinib—Dermatitis—Lamivudine—hepatitis B	0.000879	0.00177	CcSEcCtD
Trametinib—Headache—Lamivudine—hepatitis B	0.000875	0.00176	CcSEcCtD
Trametinib—Nausea—Lamivudine—hepatitis B	0.000829	0.00167	CcSEcCtD
Trametinib—MAP2K1—DAP12 interactions—PTEN—hepatitis B	0.000284	0.000638	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—PTEN—hepatitis B	0.000284	0.000638	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—PTEN—hepatitis B	0.000284	0.000638	CbGpPWpGaD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	0.000283	0.000638	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IFNA1—hepatitis B	0.000283	0.000638	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—NFKB1—hepatitis B	0.000282	0.000635	CbGpPWpGaD
Trametinib—MAP2K1—MyD88-independent cascade—IL6—hepatitis B	0.000282	0.000635	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD14—hepatitis B	0.000282	0.000634	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IFNA2—hepatitis B	0.000282	0.000634	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—CDKN1A—hepatitis B	0.000282	0.000634	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—IL6—hepatitis B	0.000281	0.000633	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—PTEN—hepatitis B	0.000281	0.000633	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—CDKN1A—hepatitis B	0.000279	0.000629	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—PTEN—hepatitis B	0.000279	0.000627	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—CDKN1A—hepatitis B	0.000278	0.000626	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—PTEN—hepatitis B	0.000277	0.000624	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—IL6—hepatitis B	0.000275	0.00062	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—CTNNB1—hepatitis B	0.000275	0.000619	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000274	0.000616	CbGpPWpGaD
Trametinib—MAP2K2—Activated TLR4 signalling—IL6—hepatitis B	0.000271	0.00061	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.000269	0.000606	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—IL6—hepatitis B	0.000269	0.000606	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.000269	0.000604	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—PTEN—hepatitis B	0.000268	0.000603	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000268	0.000602	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—IL6—hepatitis B	0.000267	0.000602	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MX1—hepatitis B	0.000267	0.000602	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000267	0.000601	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SAG—hepatitis B	0.000267	0.0006	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RIT2—hepatitis B	0.000267	0.0006	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—TNF—hepatitis B	0.000266	0.0006	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000266	0.000598	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Insulin receptor—IL6—hepatitis B	0.000266	0.000598	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	0.000265	0.000597	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD14—hepatitis B	0.000264	0.000593	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IFNA2—hepatitis B	0.000264	0.000593	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—IL6—hepatitis B	0.000263	0.000592	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TGFB1—hepatitis B	0.000262	0.00059	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—hepatitis B	0.000262	0.000589	CbGpPWpGaD
Trametinib—MAP2K2—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.000255	0.000574	CbGpPWpGaD
Trametinib—MAP2K1—Activated TLR4 signalling—IL6—hepatitis B	0.000254	0.000571	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.000252	0.000567	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IFNG—hepatitis B	0.000251	0.000565	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.000251	0.000565	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—IL6—hepatitis B	0.00025	0.000563	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RIT2—hepatitis B	0.000249	0.000561	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SAG—hepatitis B	0.000249	0.000561	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—IL6—hepatitis B	0.000249	0.000559	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000248	0.000557	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TGFB1—hepatitis B	0.000245	0.000552	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—hepatitis B	0.000245	0.000551	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TNF—hepatitis B	0.000245	0.000551	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.000239	0.000537	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IFNG—hepatitis B	0.000235	0.000529	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	0.00023	0.000517	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TNF—hepatitis B	0.000229	0.000515	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—IL6—hepatitis B	0.000227	0.000511	CbGpPWpGaD
Trametinib—MAP2K2—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000227	0.000511	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL2—hepatitis B	0.000223	0.000502	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000221	0.000498	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—IL6—hepatitis B	0.000217	0.000489	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—hepatitis B	0.000216	0.000486	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	0.000215	0.000484	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—IL6—hepatitis B	0.000214	0.000481	CbGpPWpGaD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000213	0.000478	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—IL6—hepatitis B	0.000213	0.000478	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—NFKB1—hepatitis B	0.000209	0.000471	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL2—hepatitis B	0.000209	0.00047	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—CDKN1A—hepatitis B	0.000207	0.000466	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000207	0.000465	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—PTEN—hepatitis B	0.000207	0.000465	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—NFKB1—hepatitis B	0.000206	0.000463	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—IL6—hepatitis B	0.000204	0.00046	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—IL6—hepatitis B	0.000203	0.000458	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—IL6—hepatitis B	0.000203	0.000458	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—IL6—hepatitis B	0.000202	0.000455	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—hepatitis B	0.000202	0.000454	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—IL6—hepatitis B	0.000201	0.000453	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HSPA5—hepatitis B	0.0002	0.000451	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—IL6—hepatitis B	0.0002	0.00045	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—NFKB1—hepatitis B	0.000196	0.00044	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—CDKN1A—hepatitis B	0.000194	0.000436	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—PTEN—hepatitis B	0.000193	0.000435	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000193	0.000435	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—TLR4—hepatitis B	0.000193	0.000435	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—NFKB1—hepatitis B	0.000192	0.000433	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—IL6—hepatitis B	0.000191	0.00043	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—IL6—hepatitis B	0.00019	0.000428	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.000189	0.000426	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—IL6—hepatitis B	0.000189	0.000426	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—IL6—hepatitis B	0.000189	0.000426	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DPB1—hepatitis B	0.000189	0.000426	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—IL6—hepatitis B	0.000189	0.000426	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—IL6—hepatitis B	0.000188	0.000424	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—IL6—hepatitis B	0.000188	0.000422	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HSPA5—hepatitis B	0.000188	0.000422	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—IL6—hepatitis B	0.000186	0.000419	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—IL6—hepatitis B	0.000185	0.000417	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000182	0.00041	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TLR2—hepatitis B	0.000182	0.00041	CbGpPWpGaD
Trametinib—MAP2K2—Disease—GOT2—hepatitis B	0.000181	0.000407	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNB1—hepatitis B	0.000181	0.000407	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—TLR4—hepatitis B	0.000181	0.000407	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CXCL10—hepatitis B	0.000178	0.000401	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—IL6—hepatitis B	0.000177	0.000399	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.000177	0.000399	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—IL6—hepatitis B	0.000177	0.000399	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DPB1—hepatitis B	0.000177	0.000399	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNA1—hepatitis B	0.000176	0.000397	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—IL6—hepatitis B	0.000176	0.000395	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—IL6—hepatitis B	0.000174	0.000392	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—IL6—hepatitis B	0.000173	0.00039	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TLR2—hepatitis B	0.00017	0.000383	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GOT2—hepatitis B	0.000169	0.000381	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNB1—hepatitis B	0.000169	0.000381	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000168	0.000378	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL10—hepatitis B	0.000167	0.000375	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNA1—hepatitis B	0.000165	0.000371	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD14—hepatitis B	0.000164	0.000369	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNA2—hepatitis B	0.000164	0.000369	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000162	0.000365	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000157	0.000353	CbGpPWpGaD
Trametinib—MAP2K2—Disease—GOT1—hepatitis B	0.000156	0.000351	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD14—hepatitis B	0.000154	0.000346	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNA2—hepatitis B	0.000154	0.000346	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000152	0.000341	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GOT1—hepatitis B	0.000146	0.000329	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL18—hepatitis B	0.00014	0.000315	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD40LG—hepatitis B	0.00014	0.000314	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000138	0.000311	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCR5—hepatitis B	0.000138	0.000311	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD8A—hepatitis B	0.000138	0.000311	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—CTNNB1—hepatitis B	0.000137	0.000308	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD4—hepatitis B	0.000136	0.000306	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKR1B1—hepatitis B	0.000136	0.000305	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—NFKB1—hepatitis B	0.000133	0.000299	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—hepatitis B	0.000131	0.000295	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL18—hepatitis B	0.000131	0.000295	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD40LG—hepatitis B	0.000131	0.000294	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GGT2—hepatitis B	0.00013	0.000293	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCR5—hepatitis B	0.000129	0.000291	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD8A—hepatitis B	0.000129	0.000291	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—hepatitis B	0.000129	0.00029	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—CTNNB1—hepatitis B	0.000128	0.000288	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD4—hepatitis B	0.000127	0.000287	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—NFKB1—hepatitis B	0.000124	0.00028	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-A—hepatitis B	0.000123	0.000277	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—hepatitis B	0.000123	0.000276	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CTNNB1—hepatitis B	0.000121	0.000272	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—hepatitis B	0.000121	0.000272	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—F2—hepatitis B	0.000119	0.000267	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CDKN1A—hepatitis B	0.000118	0.000266	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PTEN—hepatitis B	0.000118	0.000265	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—NFKB1—hepatitis B	0.000117	0.000264	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—hepatitis B	0.000117	0.000263	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CCR5—hepatitis B	0.000117	0.000262	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-A—hepatitis B	0.000115	0.000259	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HLA-A—hepatitis B	0.000114	0.000256	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CTNNB1—hepatitis B	0.000113	0.000254	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TLR4—hepatitis B	0.000113	0.000253	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DRB1—hepatitis B	0.000112	0.000253	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—F2—hepatitis B	0.000111	0.00025	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TGFB1—hepatitis B	0.000111	0.000249	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CDKN1A—hepatitis B	0.00011	0.000249	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PTEN—hepatitis B	0.00011	0.000248	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—NFKB1—hepatitis B	0.00011	0.000247	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—hepatitis B	0.000109	0.000246	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CCR5—hepatitis B	0.000109	0.000245	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HLA-A—hepatitis B	0.000106	0.000239	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TLR4—hepatitis B	0.000105	0.000237	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL10—hepatitis B	0.000105	0.000237	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DRB1—hepatitis B	0.000105	0.000237	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TGFB1—hepatitis B	0.000103	0.000233	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—hepatitis B	0.000103	0.000232	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS2—hepatitis B	9.88e-05	0.000222	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL10—hepatitis B	9.85e-05	0.000222	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—hepatitis B	9.66e-05	0.000217	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS2—hepatitis B	9.24e-05	0.000208	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—hepatitis B	8.33e-05	0.000188	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNG—hepatitis B	8.21e-05	0.000185	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR5—hepatitis B	8.16e-05	0.000184	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2—hepatitis B	7.98e-05	0.00018	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD4—hepatitis B	7.93e-05	0.000178	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2A6—hepatitis B	7.89e-05	0.000177	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—hepatitis B	7.8e-05	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNG—hepatitis B	7.68e-05	0.000173	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR5—hepatitis B	7.64e-05	0.000172	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2—hepatitis B	7.47e-05	0.000168	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD4—hepatitis B	7.42e-05	0.000167	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—hepatitis B	7.36e-05	0.000166	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.35e-05	0.000165	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD4—hepatitis B	7.32e-05	0.000165	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2—hepatitis B	7.29e-05	0.000164	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKR1B1—hepatitis B	7.29e-05	0.000164	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT2—hepatitis B	7.13e-05	0.00016	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTNNB1—hepatitis B	7.04e-05	0.000158	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—F2—hepatitis B	7e-05	0.000158	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GGT2—hepatitis B	6.99e-05	0.000157	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—hepatitis B	6.89e-05	0.000155	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1A—hepatitis B	6.88e-05	0.000155	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PTEN—hepatitis B	6.86e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD4—hepatitis B	6.85e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NFKB1—hepatitis B	6.83e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2—hepatitis B	6.82e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTNNB1—hepatitis B	6.59e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—F2—hepatitis B	6.55e-05	0.000147	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CTNNB1—hepatitis B	6.5e-05	0.000146	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1A—hepatitis B	6.44e-05	0.000145	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PTEN—hepatitis B	6.42e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NFKB1—hepatitis B	6.39e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1A—hepatitis B	6.35e-05	0.000143	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTEN—hepatitis B	6.34e-05	0.000143	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GGT1—hepatitis B	6.16e-05	0.000139	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT1—hepatitis B	6.16e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CTNNB1—hepatitis B	6.08e-05	0.000137	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1A—hepatitis B	5.94e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTEN—hepatitis B	5.93e-05	0.000133	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	5.61e-05	0.000126	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—hepatitis B	5.25e-05	0.000118	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—hepatitis B	4.91e-05	0.000111	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2—hepatitis B	4.72e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—hepatitis B	4.69e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CTNNB1—hepatitis B	4.55e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1A—hepatitis B	4.45e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTEN—hepatitis B	4.44e-05	9.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NFKB1—hepatitis B	4.42e-05	9.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2—hepatitis B	4.41e-05	9.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—hepatitis B	4.39e-05	9.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—hepatitis B	4.29e-05	9.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CTNNB1—hepatitis B	4.26e-05	9.58e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2A6—hepatitis B	4.23e-05	9.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1A—hepatitis B	4.16e-05	9.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTEN—hepatitis B	4.15e-05	9.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NFKB1—hepatitis B	4.13e-05	9.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—hepatitis B	4.01e-05	9.03e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—hepatitis B	3.96e-05	8.91e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT2—hepatitis B	3.83e-05	8.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—hepatitis B	3.7e-05	8.33e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—hepatitis B	3.68e-05	8.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—hepatitis B	3.44e-05	7.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT1—hepatitis B	3.3e-05	7.43e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GGT1—hepatitis B	3.3e-05	7.43e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—hepatitis B	3.27e-05	7.37e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—hepatitis B	3.03e-05	6.81e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—hepatitis B	2.83e-05	6.37e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—hepatitis B	2.77e-05	6.24e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—hepatitis B	2.59e-05	5.84e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTEN—hepatitis B	2.5e-05	5.62e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—hepatitis B	1.76e-05	3.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTEN—hepatitis B	1.34e-05	3.02e-05	CbGpPWpGaD
